Abstract
Purpose
To evaluate the appropriate post-injection timing for hand-held-gamma-ray-detecting probe (GDP) scanning for the intraoperative detection of malignancy after preoperative F-18 FDG (FDG) injection.
Methods
Patient study with superficially located cancer was performed on three patients before operation by dual-phase whole-body PET at 2 and 6–7 hr post-injection of FDG (370 MBq), and by probe scanning from the skin at several points at 1, 3, 5, and 7 hr after FDG injection. TNRa (tumor-adjacent-normal ratio) and TNRc (tumor-contralateral-normal ratio) were calculated. Phantom study was also performed to determine basic GDP function.
Results
The patient study revealed that tumors showed constant TNRa (0.9–1.3) and TNRc (1.1–3.0) by GDP count rate, and that there was no tendency of an increase in TNRa with time. The standard deviations of GDP count rate were lower at 1–3 hr post-injection compared with those of delayed scans. While delayed PET showed an increase or no change in the tumor FDG uptake, the decrease of normal tissue FDG uptake was not adequate to create higher TNRs. The phantom study revealed that LN model showed TNRa of 1.7 or greater by GDP count rate (cps) when background contained no FDG, but that they showed TNRa of 1.3 or less when the background contained 4% of the LN FDG activity per ml.
Conclusion
The present study suggests that higher FDG count rate of tumors at 1–3 hr post-injection would be more suitable for the gamma-probe detection compared with lower count rate at 6–7 hr delayed scans with wide standard deviations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alazraki NP, Styblo T, Grant SF, Cohen C, Larsen T, et al. Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma detecting probe.Radiol Clin North Am 2001;39 (5):947–956.
Dubois RW, Swetter SM, Atkins M, McMasters K, Halbert R, et al. Developing indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alph- 2b in melanoma.Arch Dermatol 2001; 137(9):1217–1224.
Tsavellas G, Patel H, Allen-Mersh TG. Detection and clinical significance of occult tumour cells in colorectal cancer.Br J Surg 2001;88 (10):1307–1320.
Ramires PT, Levenback C. Sentinel nodes in gynecologic malignancies.Curr Opin Oncol 2001; 13 (5):403–407.
Desai DC, Arnold M, Saha S, Hinkle G, Soble D, et al. Correlative whole-body FDG-PET and intraoperative gamma detection of FDG distribution in colorectal cancer.Clin Positron Imaging 2000;3 (5):189–196.
Zervos EE, Desai DC, DePalatis LR, Soble D, Martin EW. F-18 labelled fluorodeoxyglucose positron emission tomography- guided surgery for recurrent colorectal cancer: a feasibility study.J Surg Res 2001; 97 (1):9–13.
Essner R, Hsueh EC, Haigh PI, Glass EC, Huynh Y, et al. Application of an F-18 fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy.J Surg Res 2001; 97(1):120–126.
Hustinx R, Smith RJ, Benard F, Rosenthal DI, Machtay M, et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck.Eur J Nucl Med 1999; 26 (10):1345- 1348.
Nakamoto Y, Higashi T, Sakahara H, Tamaki N, Kogire M, et al. Delayed FDG PET Scan for Differentiation Between Malignant and Benign Lesions in the Pancreas.Cancer 2000; 89 (12):2547–2554.
Vogt H, Bachter D, Buchels HK, Wengenmair H, Dorn R, et al. Sentinel lymph node detection by preoperative lymphoscintigraphy and intraoperative gamma probe guidance in malignant melanoma.Nuklearmedizin 1999; 38 (4):95–100.
Kitano H, Magata Y, Tanaka A, Mukai T, Kuge Y, Nagatsu K, et al. Performance assessment of O-18 water purifier.Ann Nucl Med 2001; 15(1):75–78.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Higashi, T., Saga, T., Ishimori, T. et al. What is the most appropriate scan timing for intraoperative detection of malignancy using18F-FDG-sensitive gamma probe? Preliminary phantom and preoperative patient study. Ann Nucl Med 18, 105–114 (2004). https://doi.org/10.1007/BF02985100
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02985100